PAVmed Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . PAVmed Inc
PAVM Stock  USD 9.10  0.25  2.67%   
PAVmed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PAVmed's valuation are provided below:
Gross Profit
-152 K
Profit Margin
106.7241
Market Capitalization
7.1 M
Enterprise Value Revenue
1.4 K
Revenue
29 K
There are over one hundred nineteen available trending fundamental ratios for PAVmed Inc, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check out PAVmed's recent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself next year. As of the 3rd of February 2026, Market Cap is likely to drop to about 6.6 M. In addition to that, Enterprise Value is likely to drop to about 29.6 M

PAVmed Total Revenue

3.62 Million

Check PAVmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 907 K, Interest Expense of 49.2 K or Selling General Administrative of 15.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 2.4. PAVmed financial statements analysis is a perfect complement when working with PAVmed Valuation or Volatility modules.
  
Build AI portfolio with PAVmed Stock
Check out the analysis of PAVmed Correlation against competitors.

PAVmed Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets24.5 M35.3 M18.1 M
Slightly volatile
Total Current Liabilities42.8 M40.8 M15.9 M
Slightly volatile
Accounts Payable717.8 K755.5 K1.1 M
Slightly volatile
Cash1.3 M1.4 M10.5 M
Slightly volatile
Cash And Short Term Investments1.3 M1.4 M10.9 M
Slightly volatile
Common Stock Total Equity103.8 K98.9 K45.5 K
Slightly volatile
Common Stock Shares Outstanding1.2 M2 M1.2 M
Very volatile
Liabilities And Stockholders Equity24.5 M35.3 M18.1 M
Slightly volatile
Capital Surpluse239.2 M227.8 M85.7 M
Slightly volatile
Other Current Assets1 M799.2 K695.3 K
Slightly volatile
Other Stockholder Equity300.8 M286.5 M99.2 M
Slightly volatile
Total Liabilities45.5 M43.3 M16.7 M
Slightly volatile
Total Current Assets2.4 M2.5 M11.7 M
Slightly volatile
Common Stock12 K12.7 K21.3 K
Pretty Stable
Non Current Assets Total34.4 M32.8 M7.2 M
Slightly volatile
Non Current Liabilities Total3.7 M2.6 M2.4 M
Slightly volatile
Property Plant And Equipment Net2.2 M3 M1.3 M
Slightly volatile
Property Plant And Equipment Gross2.7 M4.5 M1.6 M
Slightly volatile
Property Plant Equipment6.6 M6.3 M1.9 M
Slightly volatile
Short and Long Term Debt Total23.9 M36.6 M16.3 M
Slightly volatile
Long Term Debt Total1.6 M1.7 M1.9 M
Slightly volatile
Short and Long Term Debt21.9 M33.5 M14.3 M
Slightly volatile
Short Term Debt22.5 M34.1 M14.6 M
Slightly volatile
Capital Stock2.9 M3.8 M2.5 M
Slightly volatile
Current Deferred Revenue792.5 M754.8 M131.7 M
Slightly volatile
Net Receivables15.4 K16.2 K19.3 K
Slightly volatile

PAVmed Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization907 K1.4 M767.3 K
Slightly volatile
Selling General Administrative15.8 M28.2 M12.2 M
Slightly volatile
Other Operating Expenses32.9 M54.6 M24.6 M
Slightly volatile
Research Development9.2 M6.8 M6.4 M
Slightly volatile
Non Recurring210.6 K236.9 K258.6 K
Slightly volatile
Total Operating Expenses31.3 M47.7 M23.2 M
Slightly volatile
Interest Income217.2 K228.6 K1.3 M
Slightly volatile
Preferred Stock And Other Adjustments22.6 K23.8 K66.6 K
Slightly volatile
Reconciled Depreciation944.4 K1.4 M543.5 K
Slightly volatile
Selling And Marketing Expenses13.2 M13.4 M6.7 M
Slightly volatile

PAVmed Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6 M7.4 M4.4 M
Slightly volatile
Depreciation1.4 M1.4 M571.6 K
Slightly volatile
Capital Expenditures60.1 K63.2 K217.4 K
Slightly volatile
Total Cash From Financing Activities28 M36 M20.6 M
Slightly volatile
End Period Cash Flow1.3 M1.4 M10.8 M
Slightly volatile
Change To Netincome19.6 M18.7 M7.3 M
Slightly volatile
Begin Period Cash Flow18.9 M22.6 M12.8 M
Slightly volatile
Dividends Paid9.8 B14.4 B6.9 B
Slightly volatile
Issuance Of Capital Stock30.2 M36.5 M17.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.212.33277
Slightly volatile
Dividend Yield3.0E-43.0E-43.0E-4
Slightly volatile
Days Sales Outstanding2.42.5213.5388
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue2.352.4824.9148
Slightly volatile
Capex To Depreciation0.05020.05283.2556
Slightly volatile
EV To Sales13.414.11170
Slightly volatile
Inventory Turnover21.4520.436.099
Slightly volatile
Days Of Inventory On Hand17.5718.49238
Slightly volatile
Payables Turnover8.688.271.8514
Slightly volatile
Sales General And Administrative To Revenue8.959.4244.8591
Slightly volatile
Research And Ddevelopement To Revenue2.162.2832.693
Slightly volatile
Capex To Revenue0.02010.02112.3235
Slightly volatile
Cash Per Share3.143.3184.1403
Pretty Stable
Days Payables Outstanding43.3945.6747.9 K
Slightly volatile
Intangibles To Total Assets0.03470.03870.0296
Slightly volatile
Current Ratio0.06670.07026.2716
Slightly volatile
Receivables Turnover15715033.2795
Slightly volatile
Capex Per Share0.150.17061.4539
Pretty Stable
Revenue Per Share4.868.364.0834
Slightly volatile
Interest Debt Per Share12189.06122
Slightly volatile
Debt To Assets0.820.941.0544
Slightly volatile
Operating Cycle19.9621.01343
Slightly volatile
Days Of Payables Outstanding43.3945.6747.9 K
Slightly volatile
Effective Tax Rate0.180.210.2263
Slightly volatile
Quick Ratio0.05850.06166.2626
Slightly volatile
Net Income Per E B T0.781.260.9874
Very volatile
Cash Ratio0.03650.03846.1761
Slightly volatile
Days Of Inventory Outstanding17.5718.49238
Slightly volatile
Days Of Sales Outstanding2.42.5213.5388
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.90.9892
Slightly volatile
Fixed Asset Turnover1.071.020.44
Slightly volatile
Debt Ratio0.820.941.0544
Slightly volatile
Price Sales Ratio2.212.33277
Slightly volatile
Asset Turnover0.09230.08790.0252
Slightly volatile

PAVmed Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.6 M7 M25.7 M
Slightly volatile
Enterprise Value29.6 M33.1 M39.1 M
Slightly volatile

PAVmed Fundamental Market Drivers

PAVmed Upcoming Events

12th of March 2024
Upcoming Quarterly Report
View
21st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About PAVmed Financial Statements

PAVmed investors utilize fundamental indicators, such as revenue or net income, to predict how PAVmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue754.8 M792.5 M
Total Revenue3.4 M3.6 M
Cost Of Revenue6.9 M7.3 M
Stock Based Compensation To Revenue 2.48  2.35 
Sales General And Administrative To Revenue 9.42  8.95 
Research And Ddevelopement To Revenue 2.28  2.16 
Capex To Revenue 0.02  0.02 
Revenue Per Share 8.36  4.86 
Ebit Per Revenue(13.37)(14.04)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
How To Invest In PAVmed
Details
Is PAVmed Stock a good investment?
Details
What is PAVmed's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of PAVmed Correlation against competitors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(12.00)
Revenue Per Share
0.054
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.37)
Return On Equity
0.1744
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value—what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY